ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 2 filers reported holding ENDOCYTE INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $402,000 | -65.8% | 22,608 | -95.1% | 0.02% | -60.0% |
| Q4 2016 | $1,177,000 | -18.2% | 461,561 | -0.8% | 0.06% | +25.0% |
| Q3 2016 | $1,438,000 | +54.3% | 465,206 | +60.2% | 0.04% | +15.8% |
| Q2 2016 | $932,000 | -32.1% | 290,456 | -34.4% | 0.04% | -37.7% |
| Q1 2016 | $1,372,000 | -63.0% | 442,656 | -52.2% | 0.06% | -48.7% |
| Q4 2015 | $3,712,000 | +16.2% | 925,789 | +32.8% | 0.12% | +28.0% |
| Q3 2015 | $3,194,000 | -37.3% | 697,369 | -29.0% | 0.09% | -10.6% |
| Q2 2015 | $5,097,000 | -18.5% | 981,969 | -1.7% | 0.10% | -19.4% |
| Q1 2015 | $6,256,000 | +273.7% | 999,315 | +275.3% | 0.13% | +344.8% |
| Q4 2014 | $1,674,000 | -73.8% | 266,278 | -0.9% | 0.03% | -88.7% |
| Q1 2014 | $6,396,000 | +548.0% | 268,637 | +190.6% | 0.26% | +374.1% |
| Q4 2013 | $987,000 | -48.7% | 92,446 | -36.0% | 0.05% | -56.8% |
| Q3 2013 | $1,924,000 | +21.2% | 144,365 | +19.4% | 0.12% | +2.5% |
| Q2 2013 | $1,588,000 | – | 120,909 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |